Published in Diagn Interv Radiol on March 04, 2014
Correlation Between Apparent Diffusion Coefficients and Standardized Uptake Values in Hybrid (18)F-FDG PET/MR: Preliminary Results in Rectal Cancer. Nucl Med Mol Imaging (2016) 0.75
Initial Staging of Locally Advanced Rectal Cancer and Regional Lymph Nodes: Comparison of Diffusion-Weighted MRI With 18F-FDG-PET/CT. Clin Nucl Med (2016) 0.75
Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med (2004) 2.97
Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol (2011) 2.33
Energy deregulation: licensing tumors to grow. Science (2006) 2.31
Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology (2006) 1.95
Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology (2009) 1.56
Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol (2011) 1.49
Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. AJNR Am J Neuroradiol (2001) 1.41
High-B-value diffusion-weighted MRI in colorectal cancer. AJR Am J Roentgenol (2006) 1.41
Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability. Eur Radiol (2011) 1.38
Relationship between bone marrow cellularity and apparent diffusion coefficient. J Magn Reson Imaging (2001) 1.27
Diffusion-weighted MRI for detecting and monitoring cancer: a review of current applications in body imaging. Diagn Interv Radiol (2011) 1.14
Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness. J Magn Reson Imaging (2012) 1.13
Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer. Eur J Nucl Med Mol Imaging (2008) 1.13
Value of ADC measurements for nodal staging after chemoradiation in locally advanced rectal cancer-a per lesion validation study. Eur Radiol (2010) 1.08
Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions. AJR Am J Roentgenol (2011) 1.03
Pitfalls in abdominal diffusion-weighted imaging: how predictive is restricted water diffusion for malignancy. AJR Am J Roentgenol (2009) 1.02
Diffusion-weighted magnetic resonance imaging for detecting lymph node metastasis of rectal cancer. World J Surg (2011) 1.02
Quantitative assessment of diffusion-weighted MR imaging in patients with primary rectal cancer: correlation with FDG-PET/CT. Mol Imaging Biol (2010) 1.01
Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging. Br J Radiol (2011) 1.00
Colorectal tumors: the histology report. Dig Liver Dis (2011) 0.94
Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT. Abdom Imaging (2012) 0.90
Diffusion-weighted imaging of the rectosigmoid colon: preliminary findings. J Comput Assist Tomogr (2009) 0.88
The value of metabolic imaging to predict tumour response after chemoradiation in locally advanced rectal cancer. Radiat Oncol (2010) 0.87
Diffusion-weighted imaging findings of mucinous carcinoma arising in the ano-rectal region: comparison of apparent diffusion coefficient with that of tubular adenocarcinoma. Jpn J Radiol (2011) 0.82
F-18 FDG PET/CT in rectal carcinoma: where are we now? Clin Nucl Med (2011) 0.82
Neoadjuvant treatment in rectal cancer: actual status. Chemother Res Pract (2011) 0.82
The efficacy of diffusion-weighted imaging for the detection of colorectal cancer. Hepatogastroenterology (2009) 0.81
Colorectal cancer: prognostic role of 18F-FDG-PET/CT. Abdom Imaging (2012) 0.81
Whole-body MR-DWIBS vs. [18F]-FDG-PET/CT in the study of malignant tumors: a retrospective study. Radiol Med (2011) 0.81
Congenital variants and anomalies of the pancreas and pancreatic duct: imaging by magnetic resonance cholangiopancreaticography and multidetector computed tomography. Korean J Radiol (2013) 1.33
MR imaging of a ruptured intraspinal dermoid tumour with fat droplets in the central spinal canal. Australas Radiol (2002) 1.11
Imaging features of portal biliopathy: frequency of involvement patterns with emphasis on MRCP. Eur J Radiol (2008) 1.01
[Anatomic variations of the bile ducts: MRCP findings]. Tani Girisim Radyol (2004) 0.96
Trigeminal nerve involvement in T-cell acute lymphoblastic leukemia: value of MR imaging. Eur J Radiol (2002) 0.88
Ectopic hypoplastic and multiseptate gallbladder with coexisting choledochal cyst: evaluation with sonography and magnetic resonance cholangiopancreaticography. J Clin Ultrasound (2006) 0.85
Behçet's Disease and Intracardiac Thrombosis: A Report of Three Cases. Case Rep Rheumatol (2013) 0.85
Nasolacrimal system: evaluation with gadolinium-enhanced MR dacryocystography with a three-dimensional fast spoiled gradient-recalled technique. Eur Radiol (2002) 0.85
Evaluation of the splenic vein diameter and longitudinal size of the spleen in patients with Gamna-Gandy bodies. Diagn Interv Radiol (2006) 0.80
Are we expecting too much from the diffusion-weighted MRI? Turk J Gastroenterol (2013) 0.77
Post-treatment MRI findings of hepatocellular carcinoma. Diagn Interv Radiol (2009) 0.77
MR imaging in diffuse-type hepatocellular carcinoma with synchronous portal vein thrombi. Turk J Gastroenterol (2011) 0.76
[Evidence based radiology]. Tani Girisim Radyol (2004) 0.75
Use of MRI to identify enlarged inferior gluteal and ischioanal lymph nodes and associated findings related to the primary disease. Diagn Interv Radiol (2016) 0.75
Ocular Involvement in Mantle Cell Lymphoma Detected by F 18 FDG PET/CT. Mol Imaging Radionucl Ther (2011) 0.75
Cisterna chyli: an incidental finding on MR cholangiopancreatography. AJR Am J Roentgenol (2004) 0.75
[Pancreas divisum: Diagnostic importance of MR cholangiopancreatography]. Tani Girisim Radyol (2003) 0.75
Additional Diagnostic Value of Inversion Recovery Single-Shot Fast-Spin Echo Sequence in Differentiation Between Hepatic Hemangiomas and Cysts. J Comput Assist Tomogr (2015) 0.75
Re: Tubaovarian actinomycosis presenting as colonic carcinoma*. ANZ J Surg (2009) 0.75
Perianal infections: reader agreement and diagnostic performance of fat-suppressed contrast-enhanced MRI. Australas Radiol (2003) 0.75
POEMS syndrome: a case report. Turk J Gastroenterol (2008) 0.75
Primary sclerosing cholangitis: MR cholangiopancreatography and T2-weighted MR imaging findings. Diagn Interv Radiol (2005) 0.75
Ansa pancreatica: a rare pancreas ductal variation. Turk J Gastroenterol (2008) 0.75
An unusual cause of recurrent pancreatitis: A gastric duplication cyst with an accessory pancreatic lobe. Turk J Gastroenterol (2014) 0.75
Pancreatic changes in patients with primary sclerosing cholangitis: MR cholangiopancreatography and MRI findings. Eur J Radiol (2008) 0.75
Pelvic retroperitoneal angioleiomyoma mimicking a uterine mass. Diagn Interv Radiol (2009) 0.75
Contrast-enhanced MR angiography of benign regenerative nodules following TIPS shunt procedure in Budd-Chiari syndrome. Turk J Gastroenterol (2004) 0.75